Vitamin E deficiency reduces surfactant lipid biosynthesis in alveolar type II cells

Free Radical Biology and Medicine

Volumn 34, Issue 6, 2003, Pages 663-673

  Guthmann, Florian ^a   Kolleck, Ingrid ^a   Schachtrup, Christian ^b   Schlame, Michael ^c   Spener, Friedrich ^b   Rüstow, Bernd ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Alveolar type II cell; G3P O acyl transferase; Phospholipid biosynthesis; Protein kinase C; Reacylation; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHELERYTHRINE; DITHIOTHREITOL; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; LUNG SURFACTANT; LYSOPHOSPHATIDYLCHOLINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PROTEIN KINASE C;

ACYLATION; ALPHA TOCOPHEROL DEFICIENCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HEALTH STATUS; LIPID ANALYSIS; LIPOGENESIS; LUNG ALVEOLUS CELL TYPE 2; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REGULATORY MECHANISM;

EID: 0037443628     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01376-X     Document Type: Article

References (51)

1. Brigelius-Flohe R., Traber M.G. Vitamin E function and metabolism . FASEB J. 13:1999;1145-1155.
2. Mustafa M.G., Tierney D.F. Biochemical and metabolic changes in the lung with oxygen, ozone, and nitrogen dioxide toxicity. Am. Rev. Respir. Dis. 118:1978;1061-1090.
3. Jackson R.M. Molecular, pharmacologic, and clinical aspects of oxygen-induced lung injury. Clin. Chest Med. 11:1990;73-86.
4. Meydani S.N., Beharka A.A. Recent developments in vitamin E and immune response. Nutr. Rev. 56:1998;S49-S58.
5. Chitano P., Hosselet J.J., Mapp C.E., Fabbri L.M. Effect of oxidant air pollutants on the respiratory system insights from experimental animal research . Eur. Respir. J. 8:1995;1357-1371.
6. Chan D.K., Lim M.S., Choo S.H., Tan I.K. Vitamin E status of infants at birth. J. Perinat. Med. 27:1999;395-398.
7. Farrell P.M. Vitamin E deficiency in premature infants. J. Pediatr. 95:1979;869-872.
8. Kelly F.J., Rodgers W., Handel J., Smith S., Hall M.A. Time course of vitamin E repletion in the premature infant. Br. J. Nutr. 63:1990;631-638.
9. van Golde L.M., Batenburg J.J., Robertson B. The pulmonary surfactant system biochemical aspects and functional significance . Physiol. Rev. 68:1988;374-455.
10. Hallman M. Lung surfactant in respiratory distress syndrome. Acta Anaesthesiol. Scand. Suppl. 95:1991;15-21.
11. Jobe A.H. Pathogenesis of respiratory failure in the preterm infant. Ann. Med. 23:1991;687-691.
12. Tasinato A., Boscoboinik D., Bartoli G.M., Maroni P., Azzi A. D-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. USA. 92:1995;12190-12194.
13. Sabat R., Kolleck I., Witt W., Volk H., Sinha P., Rustow B. Immunological dysregulation of lung cells in response to vitamin E deficiency. Free Radic. Biol. Med. 30:2001;1145-1153.
14. Sinha P., Kolleck I., Volk H.D., Schlame M., Rüstow B. Vitamin E deficiency sensitizes alveolar type II cells for apoptosis. Biochim. Biophys. Acta. 1583:2002;91-98.
15. Haagsman H.P., Schuurmans E.A., Batenburg J.J., van Golde L.M. Synthesis of phosphatidylcholines in ozone-exposed alveolar type II cells isolated from adult rat lung is glycerolphosphate acyltransferase a rate-limiting enzyme . Exp. Lung Res. 14:1988;1-17.
16. Batenburg J.J., Haagsman H.P. The lipids of pulmonary surfactant dynamics and interactions with proteins . Prog. Lipid Res. 37:1998;235-276.
17. 2-mediated injury to type II cell surfactant metabolism and protection with PEG-catalase. Am. J. Physiol. 261:1991;C751-C757.
18. Haagsman H.P., Schuurmans E.A., Alink G.M., Batenburg J.J., van Golde L.M. Effects of ozone on phospholipid synthesis by alveolar type II cells isolated from adult rat lung. Exp. Lung Res. 9:1985;67-84.
19. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917.
20. Rüstow B., Kunze D. The availability of endogenous and exogenous disaturated diacylglycerol for the diacylglycerol-consuming reactions in lung microsomes. Biochim. Biophys. Acta. 796:1984;359-363.
21. Dobbs L.G., Gonzalez R., Williams M.C. An improved method for isolating type II cells in high yield and purity. Am. Rev. Respir. Dis. 134:1986;141-145.
22. Kolleck I., Wissel H., Guthmann F., Schlame M., Sinha P., Rstow B. HDL-holoparticle uptake by alveolar type II cells effect of vitamin E status . Am. J. Respir. Cell Mol. Biol. 27:2002;57-63.
23. Matsuno K., Diaz-Ricart M., Montgomery R.R., Aster R.H., Jamieson G.A., Tandon N.N. Inhibition of platelet adhesion to collagen by monoclonal anti-CD36 antibodies. Br. J. Haematol. 92:1996;960-967.
24. Bonen A., Luiken J.J., Arumugam Y., Glatz J.F., Tandon N.N. Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J. Biol. Chem. 275:2000;14501-14508.
25. Kolleck I., Guthmann F., Ladhoff A.M., Tandon N.N., Schlame M., Rüstow B. Cellular cholesterol stimulates acute uptake of palmitate by redistribution of fatty acid translocase in type II pneumocytes. Biochemistry. 41:2002;6369-6375.
26. Guthmann F., Haupt R., Looman A.C., Spener F., Rüstow B. Fatty acid translocase/CD36 mediates the uptake of palmitate by type II pneumocytes. Am. J. Physiol. 277:1999;L191-L196.
27. Mason R.J., Nellenbogen J., Clements J.A. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J. Lipid Res. 17:1976;281-284.
28. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351-358.
29. Finkelstein J.N., Mavis R.D. Biochemical evidence for internal proteolytic damage during isolation of type II alveolar epithelial cells. Lung. 156:1979;243-254.
30. Rüstow B., Schlame M., Haupt R., Wilhelm D., Kunze D. Studies on the formation of dipalmitoyl species of phosphatidylcholine and phosphatidylethanolamine in pulmonary type II cells. Biochem. J. 282:1992;453-458.
31. Topbas Ö. F., Jehle R., Sinha P., Rüstow B. An electrophoretic study of vitamin E status and expression of heat shock proteins in alveolar type II and liver cells. Electrophoresis. 21:2001;3552-3557.
32. Witt W., Kolleck I., Fechner H., Sinha P., Rüstow B. Regulation by vitamin E of the scavenger receptor BI in rat liver and HepG2 cells. J. Lipid. Res. 41:2000;2009-2016.
33. Catignani G.L., Bieri J.G. Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin. Chem. 29:1983;708-712.
34. Thomas P.D., Poznansky M.J. Lipid peroxidation inactivates rat liver microsomal glycerol-3-phosphate acyl transferase. Effect of iron and copper salts and carbon tetrachloride. J. Biol. Chem. 265:1990;2684-2691.
35. Azzi A., Aratri E., Boscoboinik D., Clement S., Ozer N.K., Ricciarelli R., Spycher S. Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation. Biofactors. 7:1998;3-14.
36. Bendich A., Gabriel E., Machlin L.J. Dietary vitamin E requirement for optimum immune responses in the rat. J. Nutr. 116:1986;675-681.
37. Schünemann H.J., Grant B.J., Freudenheim J.L., Muti P., Browne R.W., Drake J.A., Klocke R.A., Trevisan M. The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am. J. Respir. Crit. Care Med. 163:2001;1246-1255.
38. Taylor C.G., McCutchon T.L., Boermans H.J., DiSilvestro R.A., Bray T.M. Comparison of Zn and vitamin E for protection against hyperoxia-induced lung damage. Free Radic. Biol. Med. 22:1997;543-550.
39. Ricciarelli R., Zingg J.M., Azzi A. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation. 102:2000;82-87.
40. Post M., Batenburg J.J., van Golde L.M., Smith B.T. The rate-limiting reaction in phosphatidylcholine synthesis by alveolar type II cells isolated from fetal rat lung. Biochim. Biophys. Acta. 795:1984;558-563.
41. Rüstow B., Kunze D., Rabe H., Reichmann G. The molecular species of phosphatidic acid, diacylglycerol and phosphatidylcholine synthesized from sn-glycerol 3-phosphate in rat lung microsomes. Biochim. Biophys. Acta. 835:1985;465-476.
42. Rüstow B., Kunze D. Further evidence for the existence of different diacylglycerol pools of the phosphatidylcholine synthesis in microsomes. Biochim. Biophys. Acta. 921:1987;552-558.
43. Jain S.K., Wise R., Bocchini J.J. Vitamin E and vitamin E-quinone levels in red blood cells and plasma of newborn infants and their mothers. J. Am. Coll. Nutr. 15:1996;44-48.
44. Rodriguez-Pena A., Rozengurt E. Disappearance of Ca2+-sensitive, phospholipid-dependent protein kinase activity in phorbol ester-treated 3T3 cells. Biochem. Biophys. Res. Commun. 120:1984;1053-1059.
45. Herbert J.M., Augereau J.M., Gleye J., Maffrand J.P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172:1990;993-999.
46. Lundmark J.L., Ramasamy R., Vulliet P.R., Schaefer S. Chelerythrine increases Na-K-ATPase activity and limits ischemic injury in isolated rat hearts. Am. J. Physiol. 277:1999;H999-H1006.
47. Sweeney J.F., Nguyen P.K., Atkins K.B., Hinshaw D.B. Chelerythrine chloride induces rapid polymorphonuclear leukocyte apoptosis through activation of caspase-3. Shock. 13:2000;464-471.
48. Yu R., Mandlekar S., Tan T.H., Kong A.N. Activation of p38 and c-Jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C. J. Biol. Chem. 275:2000;9612-9619.
49. Yamamoto S., Seta K., Morisco C., Vatner S.F., Sadoshima J. Chelerythrine rapidly induces apoptosis through generation of reactive oxygen species in cardiac myocytes. J. Mol. Cell. Cardiol. 33:2001;1829-1848.
50. Le-Corvoisier P., Lacotte J., Laplace M., Crozatier B. Interaction of chelerythrine with inositol phosphate metabolism. Fundam. Clin. Pharmacol. 16:2002;31-37.
51. Johnson L., Bowen F.W. Jr., Abbasi S., Herrmann N., Weston M., Sacks L., Porat R., Stahl G., Peckham G., Delivoria-Papadopoulos M. Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less. Pediatrics. 75:1985;619-638.